Fidelity Investments’s Five Prime Therapeutics, Inc. FPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-864,288
| Closed | -$14.7M | – | 4769 |
|
|
2020
Q4 | $14.7M | Buy |
864,288
+863,888
| +215,972% | +$14.7M | ﹤0.01% | 1835 |
|
|
2020
Q3 | $2K | Buy |
+400
| New | +$2K | ﹤0.01% | 3514 |
|
|
2020
Q2 | – | Sell |
-1,250
| Closed | -$3K | – | 4391 |
|
|
2020
Q1 | $3K | Buy |
1,250
+750
| +150% | +$1.8K | ﹤0.01% | 3370 |
|
|
2019
Q4 | $2K | Sell |
500
-301,512
| -100% | -$1.21M | ﹤0.01% | 3610 |
|
|
2019
Q3 | $1.17M | Sell |
302,012
-1,506,672
| -83% | -$5.84M | ﹤0.01% | 2397 |
|
|
2019
Q2 | $10.9M | Sell |
1,808,684
-1,890,384
| -51% | -$11.4M | ﹤0.01% | 1850 |
|
|
2019
Q1 | $49.6M | Sell |
3,699,068
-8,700
| -0.2% | -$117K | 0.01% | 1216 |
|
|
2018
Q4 | $34.5M | Sell |
3,707,768
-328,545
| -8% | -$3.06M | ﹤0.01% | 1322 |
|
|
2018
Q3 | $56.2M | Sell |
4,036,313
-1,245,050
| -24% | -$17.3M | 0.01% | 1215 |
|
|
2018
Q2 | $83.5M | Buy |
5,281,363
+52,319
| +1% | +$827K | 0.01% | 1034 |
|
|
2018
Q1 | $89.8M | Buy |
5,229,044
+889,538
| +20% | +$15.3M | 0.01% | 1032 |
|
|
2017
Q4 | $95.1M | Buy |
4,339,506
+4,240
| +0.1% | +$92.9K | 0.01% | 1017 |
|
|
2017
Q3 | $177M | Buy |
4,335,266
+17,447
| +0.4% | +$714K | 0.02% | 728 |
|
|
2017
Q2 | $130M | Sell |
4,317,819
-25,682
| -0.6% | -$773K | 0.02% | 856 |
|
|
2017
Q1 | $157M | Buy |
4,343,501
+77,381
| +2% | +$2.8M | 0.02% | 799 |
|
|
2016
Q4 | $214M | Buy |
4,266,120
+14,642
| +0.3% | +$734K | 0.03% | 637 |
|
|
2016
Q3 | $223M | Buy |
4,251,478
+1,434,270
| +51% | +$75.3M | 0.03% | 619 |
|
|
2016
Q2 | $116M | Buy |
2,817,208
+547,808
| +24% | +$22.7M | 0.02% | 907 |
|
|
2016
Q1 | $92.2M | Buy |
+2,269,400
| New | +$92.2M | 0.01% | 999 |
|